Rennova Pharmaceuticals Private Limited
About Rennova Pharmaceuticals Private Limited
Data last updated:
Rennova Pharmaceuticals Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2020PTC195946.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sagar Raghunath Gajabar and Pravin Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sagar Raghunath Gajbar 14/1/1 Gajbar Mala Sarnobatwadi Karvir, Kolhapur, Maharashtra, India – 416004.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.86 Lakh, a decline of 40% compared to the previous year. For the same year it recorded a net profit of ₹64,117 (net margin 0.8%) and EBITDA of ₹3.25 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 785% over three years.
Company details
Contact details
Rennova Pharmaceuticals Private Limited's registered office is in Kolhapur, Maharashtra.
- Registered AddressC/O Sagar Raghunath Gajbar 14/1/1 Gajbar Mala Sarnobatwadi Karvir, Kolhapur, Maharashtra, India – 416004
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rennova Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Rennova Pharmaceuticals Private Limited, buy the company report.
Financials of Rennova Pharmaceuticals Private Limited
FY 2025 filings availableRennova Pharmaceuticals Private Limited reported revenue of ₹80.86 Lakh (down 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 40% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 785%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹64,117 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rennova Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rennova Pharmaceuticals Private Limited
Rennova Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sagar Raghunath Gajabar | Director | 11 Nov 2020 | 5 Years 11 Months | Current |
| Pravin Patil | Director | 11 Nov 2020 | 5 Years 11 Months | Current |
| Sanjay Vitthal Patil | Director | 11 Nov 2020 | 5 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Rennova Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rennova Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rennova Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rennova Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Manesh Davhid Hegade ceased to be Director on 22 May 2024.
Frequently asked questions
Rennova Pharmaceuticals is an active private limited company based in Kolhapur, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 November 2020 (6+ years old) and is registered under CIN U24239PN2020PTC195946.
Rennova Pharmaceuticals has 3 current directors:
- Sagar Raghunath Gajabar - Director
- Pravin Patil - Director
- Sanjay Vitthal Patil - Director
The latest financial statements of Rennova Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Rennova Pharmaceuticals is U24239PN2020PTC195946. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rennova Pharmaceuticals was incorporated on 11 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Pune.
Manesh Davhid Hegade ceased to be Director on 22 May 2024. Pravin Patil was appointed as Director on 11 Nov 2020. Sagar Raghunath Gajabar was appointed as Director on 11 Nov 2020. Rennova Pharmaceuticals has 4 board changes on record in total.
The registered office of Rennova Pharmaceuticals is at CO Sagar Raghunath Gajbar 1411 Gajbar Mala Sarnobatwadi Karvir, Kolhapur, Maharashtra, India – 416004.
Rennova Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Rennova Pharmaceuticals can be reached at its registered office: CO Sagar Raghunath Gajbar 1411 Gajbar Mala Sarnobatwadi Karvir, Kolhapur, Maharashtra, India – 416004.
Rennova Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
